{"disease":{"id":"recurrence-of-overactive-bladder-syndrome","name":"recurrence of overactive bladder syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04550702","title":"Predictors for Retreatement of OAB After DC Mirabegron","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}